Recombinant vaccinia virus having hepatitis C virus gene

Details for Australian Patent Application No. 2009220401 (hide)

Owner Tokyo Metropolitan Organization for Medical Research The ChemoSero-Therapeutic Research Institute

Inventors Murai, Fukashi; Kohara, Michinori

Agent FB Rice

Pub. Number AU-A-2009220401

PCT Pub. Number WO2009/110644

Priority 2008-057515 07.03.08 JP; 2008-294361 18.11.08 JP

Filing date 6 March 2009

Wipo publication date 11 September 2009

International Classifications

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

30 September 2010 PCT application entered the National Phase

  PCT publication WO2009/110644 Priority application(s): WO2009/110644

29 September 2011 Alteration of Name

  The name of the applicant has been altered to The Chemo-Sero-Therapeutic Research Institute; Tokyo Metropolitan Institute of Medical Science

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009220403-Agents for promoting secretion and/or suppressing decrease of adiponectin

2009220400-Azo pigments, and pigment dispersion, coloring composition and ink for inkjet recording containing the azo pigment